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Abstract
Background: The incidence of Prostate Enlargement (PE) has been increasing over the years. The satisfaction towards the treatment result and life quality (QOL) improvement must be the key point of PE treatment. QOL is affected by many conditions, such as age, socioeconomic status, comorbid disease, and type of surgery. The objective of the study was to assess the QOL in PE patients post surgery, to explore the predictor factor, and to assess the satisfaction related to urinary functionality in the Indonesian context. 
Methods: A retrospective study was conducted and the subjects were all PE patients who underwent surgical treatment. EQ-5D-5L/EQ-VAS and Index Quality of Life (IQL) were used to assess the patient’s QOL & treatment satisfaction. The subjects were divided into several sub-groups based on age, type of surgery, comorbid condition, type of ward, funding source, histopathological result, and the year of treatment. The collected data wee analyzed using Mann-Whitney test, Kruskal Wallis test, or Chi-square test, Spearman’s rho test and multiple linear regression.
Results: All the 149 subjects were at the average age of 69.09 years . There were no significant statistical differences in QOL between age, comorbid conditions, and histopathology result. Health insurance (HI) was 
significantly associated with QOL. There were improvements of IQL subjects. The most symptoms remaining was frequency (47.4%).
Conclusions: Life improvement must be the major purpose of PE therapy. The association between HI with QOL suggests that a better HI in developing countries can ensure a better quality of life outcome. 
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IntroductionProstatic enlargement either Benign Prostate Hyperplasia (BPH) or Prostate Cancer, is the most common urologic disorder in the elderly population.1 The incidence of BPH has been increasing over the years. The risk of BPH increases with age and several studies have shown that BPH incidence is as high as 90% in people over 70 years old.2 Prostate cancer prevalence in Indonesia was 0.2% in 2013 which equals to 25,012 patients. This makes prostate cancer the second most common high-mortality rate disease experienced in Indonesia.3,4 The BPH usually is not a life threatening disease, but rather affects people’s quality of life (QOL). Therefore the primary goal of 
treatment should be improving the patient‘s QOL,1 especially related to social activities and general feeling of well-being. The QOL affected by many conditions, such as age, socioeconomic status, comorbid disease, and type of surgery.5,6 Health Related Quality of Life (HRQOL) assessment tools can be used to evaluate patient satisfaction before and after treatment. There are several questionnaires used to evaluate patients HRQOL in patients who suffer from prostate disease such as the International Prostate Symptom Score (IPSS); Sexual Functioning Index (SFI); BPH Impact Index (BII) and EQ-5D Index (EQ-5D Index).7-9The diagnosis and treatment of prostatic 
enlargement disease have made significant advances in past years. The gold standard of radical prostatectomy has nowadays been 
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largely replaced by endourological treatment. For example, Transurethral Resection of the Prostate (TURP), when compared to radical prostatectomy and medical treatment is far less invasive, and is associated with fewer complications, shorter hospitalization, better outcomes, better quality of life improvement and reduced cost.10Both medical and surgery treatments are known to increase the HRQOL of patients with prostatic disease, especially those who have moderate-severe lower urinary 
tract symptoms (LUTS) but no significant difference in effect is observed between the two modalities.8,11,12 In addition HRQOL is affected by other factors such as culture and geographic area. It has been shown that HRQOL differs between European and Asian men with Hepatocellular Carcinoma13 but no such study of HRQOL in patients with prostate disease exists.The aim of this study was to asses the HRQOL in patients with prostatic enlargement disease post surgery, to explore possible predictor of worse HRQOL following prostatic surgery, and to assess patient satisfaction related urinary functionality post surgery, in the Indonesian context.
MethodsThis study evaluated BPH surgical data recorded by medical records at Bethesda hospital, Yogyakarta. The subjects were all patients with BPH and/or prostate cancer who underwent surgical treatment, either TURP or Radical Prostatectomy, in the period of January 2014–January 2016. The study was approved by the Ethics Committee of the Faculty of Medicine, Duta Wacana Christian University. Data collection included age, phone number, address, admission date, date of surgery, date of hospital discharge, type of surgery, comorbid conditions, ward type, funding source, histopathological result, and functional status. The outcomes were followed up by phone interviews.Subjects were asked to answer the questionnaire over the phone. Exclusion criteria were those patients with incomplete medical data, those who did not answer the phone or had passed away.The EQ-5D-5L/EQ-VAS was used to assess the subject’s HRQOL. EQ-5D-5L is an international questionnaire consisting of 5 questions that evaluates mobility, self-care, daily activity, pain, and depression. Each item is evaluated using a 5 point Likert scale 
with answers ranging from 1 to 5 points (no problems, slight problems, moderate problems, severe problems, and extreme problems).The summary index was calculated using the EQ-5D-5L Crosswalk Index Value Calculator. This tool was downloaded from the EuroQol website. The EQ-5D-5L index ranges from 1 (full health related quality of life) to 0 (death).15 The specific values were derived from Thailand samples because there were 
no specific sets available for the Indonesian population.EQ-VAS (Visual Analog Score) was used to evaluate the health related quality of life using the subject’s personal assessment, ranging from 0 (worst health state) to 100 (best health state). Permission for the use of this instrument in the study was granted by the EuroQol Group.Furthermore, urinary function related quality of life was assessed using the Index Quality of Life questions in IPSS (IPSS-Q8). The question “If you were to spend the rest of your life with your urinary condition just the way it is now, how would you feel about that?” was translated into Indonesian language accounting for the fact that a few people speak English. The subjects were asked to recall their feelings 3 months post surgery, 6 months post surgery, and on the day of the phone call. The question was answered according to a 7 point Likert scale, with 1 being ‘Delighted’ 
2: ‘Pleased’, 3: ‘Mostly Satisfied’, 4: ‘Mixed’, 
5: ‘Mostly Dissatisfied’, 6: ‘Unhappy’, and 7: ‘Terrible’.The possible factor of worse EQ-5D-5L was assessed by dividing them based on the 
following sub-group: 1) Age (≤ 60 y.o. vs > 
60 y.o.), defined as age when surgery was performed. The group was divided based on 
WHO and Indonesian law definition of elderly, 2) Comorbid (With Comorbid vs Without 
Comorbid), defined as the presence of one or more additional disease, 3) Type of Surgery 
(Open Prostatectomy vs TURP), defined as the surgery technique which was used as PE treatment, 4) Functional status, was based on Instrumental activities of daily living (IADL), 5) Funding Source (Family vs ASKES/BPJS (National Health Insurance), vs BUMN (State-Owned Enterprise), vs other), represented the socioeconomic status, 6) Ward Type (class 1 vs class 2 vs class 3 vs VIP vs VVIP), represented the  socioeconomic status and in-hospital environment, 7) Histopathological result (BPH vs Adenocarcinoma), Histopathological result was proven by specimen biopsy, and 7) Year 
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Table 1 Subject’s Characteristics
Variable Frequency (n) Mean±SD Range (years)Age 149 69.09 52-91Category Frequency (n) Percentage(%)
Length of Stay 1-3 Days 135 90.64-6 Days 10 6.7
>7 Days 3 2Preoperation Waiting Time 1-3 Days 12 8.14-6 Days 96 64.4
>7 Days 40 26.8
Type of Ward
Class 1 36 24.2Class 2 22 14.8Class 3 44 29.5Class VIP 36 24.2Class VVIP 1 0.7
Funding Source Family 50 33.6NHI 71 47.7DHI 7 4.7Others 11 7.4
Functional Status Fully active 141 94.6Restricted activity 4 2.7Partial dependent 3 2Completely disabled 1 0.7Type of Surgery Radical Prostatectomy 11 7.4TURP 138 92.6Histopathology Result BPH 105 70.5Adenocarcinoma 19 12.8Note: VIP=Very Important Person; VVIP=Very Very Important Person; NHI=National Health Insurance; DHI=District Health Insurance; JVP=Jugular Venous Pressure; ECG=Electrocardiograph; RPM=Rate per Minute; TURP=Trans Urethral Resection of Prostate; BPH=Benign Prostate Hyperplasia
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of Treatment (2014 vs 2015), defined as one year or two years after surgery. Besides , the frequency of answers from IQL index were also compared between 3 and 6 months post surgery and on the day when answering the questionnaire. The sample size was determined by the 
N=[(Zα+Zβ)/C]2+3. Zα was The standard 
normal deviate for α, Zβ was The standard 
normal deviate for β, and C was 0.5 * ln[(1+r)/
(1-r)]. The number of samples for this study was 123 subjects. As for the statistical analysis, categorical data were presented as frequency and percentage. Continuous data were presented as a mean or standard deviation. Kolmogorov-Smirnov test was used 
to determine the data distribution. Mann-Whitney test , Kruskal Wallis test, or Chi-square test was used, whether it was appropriate to asses the difference or not. The correlation between outcomes and variables were assessed using Spearman’s rho test. Multiple linear regression was used to asses predictor 
influences. Moreover, p value less than 0.05 and p value less than 0.001 (Spearman) were 
considered significant. 
ResultsThere were 149 subjects with an average 
age of 69,09 years . Specifically, the youngest 
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age was 52 years, while the oldest was 91 years old. Moreover, 24.2% of subjects were patients of class 1 ward and VIP. While, 47.7% of subjects used the National Health Insurance as their funding source. Furthermore, 92.4% of subjects underwent TURP surgery with 70.5% of them showing BPH on their Histopathological result (Table 1).
About 54.4% of the subjects answered 11111 in the EQ-5D-5L questionnaire and 14.1% of them answered 11222. The results of EQ-5D showed there were moderate problems in the usual activities and anxiety components.The EQ-5D-5L Index relationship was analyzed with each variable based on the sub-group, following age, comorbid, type of 
Table 2 EQ-5D Index correlation between Variables
Variables Mean (SD) p-value* p-value**Age 0.413 0.000     ≤ 60 years 81.2(0.174)
     > 60 years 73.87(0.145)Comorbid Conditions 0.368 0.000     Without Comorbid 77.7(0.178)     With Comorbid 71.87(0.165)Type of Surgery 0.994 0.000     Radical Prostatectomy 74.91(0.187)     TURP 75.01(0.165)Functional Status
0.184 0.000     Fully active 75.6     Restricted activity 36.63     Partial dependent 86.83     Completely disabled 109Funding Source
< 0.05 0.000     Family 67.37(0.175)     National Health Insurance 76.00(0.158)     District Health Insurance 37.47(0.240)     Others 63.95(0.142)Type of Ward
0.403 0.000     Class 1 68.14(0.173)     Class 2 59.66(0.193)     Class 3 76.64(0.163)     VIP 69.19(0.170)     VVIP 101.5Histopathology result 0.292 0.000     BPH 63.18(0.169)     Adenocarcinoma 55.24(0.181)Year of Treatment 0.819 0.000     2014 (≤ 1 year) 75.71(0.167)
     2015 (> 1 Year) 74.23(0.175)
Note: p-value*=P-value of Spearman correlation test, p-value**=P-value of Kolmogorov-Smirnov test
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Table 3 Responses to EQ-5D by Variables
Variables n Mobility Self Care Usual activities
Pain/
discomfort
Anxiety/
depressionAge
     ≤ 60 years 23 70.5 72.74 70.37 65.93 72.35
     > 60 years 126 75.82 75.41 75.85 76.65 75.48     p- value 0.188 0.546 0.446 0.193 0.706Comorbid Conditions     Without Comorbid 87 73.93 74.64 75.56 74.76 74.9     With Comorbid 62 76.51 75.51 74.21 75.34 75.14     p-value 0.383 0.789 0.797 0.923 0.969Type of Surgery     Radical Prostatectomy 11 77.27 76.27 70.95 80.36 72.23     TURP 138 74.82 74.9 75.32 74.57 75.22     p-value 0.66 0.822 0.66 0.611 0.795Functional Status     Fully active 141 75.26 75.31 74.94 74.94 74.59     Restricted activity 4 70.5 69.5 94.5 94.5 100.63     Partial dependent 3 70.5 69.5 57.5 57.5 70     Completely disabled 1 70.5 69.5 57.5 57.5 45.5     p-value 0.91 0.88 0.435 0.067 0.446Funding Source     Family 50 69.67 71.45 71.44 73.08 70.48     National Health Insurance 71 68.44 67.44 66.13 65.01 65.23     District Health Insurance 7 95.29 94.29 105.14 92.14 90.79     Others 11 65.5 64.5 66.05 74.09 85.41     p-value 0.001 0.003 0.01 0.169 0.105Type of Ward     Class 1 36 69.36 68.36 72.67 73.89 70.39     Class 2 22 74.98 73.98 76.2 77.75 78.48     Class 3 44 68.66 69.24 64.48 63.53 66.35     VIP 36 69.36 70.29 70.75 70.03 69.64     VVIP 1 65.5 64.5 53.5 43 43     p-value 0.683 0.841 0.541 0.429 0.646Histopathology Result     BPH 105 62.04 62.22 62.56 60.67 62.07     Adenocarcinoma 19 65.03 64.03 62.18 72.63 64.89     p-value 0.434 0.67 0.954 0.109 0.708Year of Treatment
     2014 (≤ 1 year) 78 74.32 74.28 75.53 73.24 75.47
     2015 (> 1 Year) 71 75.75 75.8 74.42 76.93 74.49     p-value 0.625 0.635 0.832 0.536 0.87
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surgery, functional status, funding source, ward type, histopathological result, and year of treatment (Table 2 and 3). Kolmogorov-Smirnov normality test was used to determine data distribution in all variables (p=0.000). Based on EQ-VAS measurement, this study discovered that the average of VAS results in male population aged 40-49 years was 78,3, aged 50-59 years was 75,5, while aged 60-69 years was 72. The mean of EQ-5D VAS was 74.06 and standart deviation was 6.350.Furthermore, the EQ-5D index correlation between variables showed age below 60 years, subjects without comorbid, used national health insurance as the funding source, and histopathological result with changing BPH had higher average compared to their comparators, 
but was not statistically significant (Age 81.2 vs 73.87, p=0.413; Comorbid condition 77.8 vs 71.87, p=0.368; Type of surgery 74.91 vs 75.01, p=0.994; Functional status 75.6 vs 36.63 vs 86.83 vs 109, p=0.184; Type of ward 68.14 vs 59.66 vs 76.64, vs 69.19 vs 101.5, p=0.184; Histopathology result 63.18 vs 55.24, p=0.292; Year of treatment 75.71 vs 74.23, p = 0.819). 
The funding source was the only variable that 
was statistically significant different (Funding source 67.37 vs 76.00 vs 37.47 vs 63.95, p<0.05). The result was similar when we assessed variables to each EQ-5D components. There was no relationship between each variables (Table 4).Moreover, the subjects’ IQL-IPSS-Q8 correlation based on the period were: 3 months after surgery, 6 months after surgery, 
and the recent condition during filling out the questionnaire revealed that there was an increase of “pleased” and a decrease of “mostly 
dissatisfied” answers from 3 months after 
surgery to the recent condition during filling out the questionnaire . In addition, an increase of urinary frequency (47.4%), nocturia (21.1%), and dysuria (10.5%) became the most frequent complaints post surgery (Table 5).
DiscussionsThe average age of subjects in this study was 69.06 years. This was in line with the rate of 
Table 4 Multiple Analysis Regression between EQ-5D Index with Variables
Variables p-valueAge 0.094Comorbid Conditions 0.352Type of Surgery 0.46Functional Status 0.256Funding Source 0.162Type of Ward 0.357Histopathology Result 0.215Year of Treatment 0.298
Table 5 Bothersome Symptoms in the Follow-up after Surgery
Variable Frequency (n) Precentage (%)Frequency 18 47.4Nocturia 8 21.1Dysuria 4 10.5Hematuria 2 5.3Obstruction 2 5.3Erectile Dysfunction 1 2.6Urgency 2 5.3Retrograde Ejaculation 1 2.6
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life expectancy in 2012 (70,1 years).3 The 
definition of elderly varied in each country. According to WHO, elderly means male or female aged over 60 years. The subjects were divided into several categories, including age. The number of subjects aged over 60 years  was the majority. This was surely in accordance with the incidence of prostate enlargement that increase in the age of over 60 years.16,17 Almost all of the subjects (32%) only experienced less than 3 days hospitalization and brought the catheter along to their home. This was shorter than in the study of Khan18, which has found that the average duration of hospitalization is 3.5 days. Changes in the urine color to clearer one, or urine is free from visible blood trace, may be the indicator of the patients’ hospital discharge.19 It might occur to almost all of the subjects who used the National Health Insurance (ASKES/BPJS) as their funding source, which highly affected their duration of hospitalization since it could decrease the patients’ total charge.There were different EQ-5D-5L average between age (sub-group) and comorbid, even 
though it was not statistically significant. Mobility impairment, previous history of stroke, respiratory disorder, and cardiovascular disease such as hypertension played a critical role in affecting the patients’ quality of life after 
surgery, both surgical and medical. This finding is obviously in accordance with the study conducted by Cortez-Diaz et al.19 Furthermore, the funding source became the only variable 
that significantly affected the patients’ quality of life. This fact shows that patients living in developing countries such as Indonesia, where most of the citizen depends on the national health insurance, really need such assurance to get the best medication from government programs so that they can reach their therapy targets. Again, this fact is supported by a study conducted by Jo et al.20 which revealed that the 
influence of status of social-economy, culture, ethnic, and religious background is real. The subjects’ VAS correlation based on sub-group with populations, generally could help the researcher to interpret the result. This study discovered that the EQ-VAS was lower than the general population which is in line with what Cortez-Diaz et al.11 has found. This fact showed that prostate enlargement affects the patients’ quality of life. Furthermore, there was a clear change in the IQL questionnaire. The “pleased” answer of 3 months post surgery with recent condition on the day when answering the questionnaire showed a degree of increase, while the 
“mostly dissatisfied” answer experienced the opposite. However, as the subjects had not reached their better condition yet at the time the researcher gave the questionnaire, there was a change over the 6 months after surgery, such as the decrease in “pleased” 
answer and increase in “mostly satisfied” answer. This was due to the clinical perception of adapting or accepting urination quality by patients, or by the improvement on patients’ remaining complaints after surgery. The most frequent complaint was what the patients described as overactive bladder. Even more, a subject suffered from erectile dysfunction or retrograde ejaculation. As a conclusion, life improvement must be the major purpose of prostate enlargement therapy, especially BPH. The researcher 
figures out that the existing therapy can improve the patients’ quality of life, even though it still has many weaknesses so the optimal therapy cannot be obtained. It is also necessary to prevent complaints that affect the patients’ quality of life after surgery as much as possible. Furthermore, the government in developing countries should consider about 
the financial guarantee of medication, in order to establish healthy citizens with good quality of life, especially of the elderly.The limitation of this study was the questionnaire data had been collected only via phone call so that perception or understanding over the questions could be varied in each subject. In addition, long term medication, and the number of subjects living outside the city were considered as the obstacle which occurs in this study. However, this study has several advantages to point out such as: it was conducted in Indonesia as one of the developing countries in the world, and provided subjects who had undergone surgery in the previous one or two years, so that health providers could observe their patients’ treatment results accordance with their  quality of life.
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